Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1CNS 1

Conditions

Leukemia, Myeloid, Acute 78Precursor Cell Lymphoblastic Leukemia-Lymphoma 65Myelodysplastic Syndromes 59Leukemia, Lymphocytic, Chronic, B-Cell 56Lymphoma, Non-Hodgkin 55Multiple Myeloma 52Hodgkin Disease 52Leukemia 48Lymphoma, Mantle-Cell 43Lymphoma 39Lymphoma, Follicular 38Leukemia, Myelogenous, Chronic, BCR-ABL Positive 38Myeloproliferative Disorders 36Lymphoma, B-Cell, Marginal Zone 36Lymphoma, Large B-Cell, Diffuse 35Burkitt Lymphoma 34Leukemia, Myelomonocytic, Chronic 30Congenital Abnormalities 30Lymphoma, Large-Cell, Immunoblastic 27Waldenstrom Macroglobulinemia 26Leukemia, Myeloid, Accelerated Phase 25Leukemia, Myeloid, Chronic-Phase 23Hematologic Neoplasms 22Blast Crisis 22Primary Myelofibrosis 21Anemia, Refractory, with Excess of Blasts 21Dendritic Cell Sarcoma, Interdigitating 20Lymphoma, T-Cell, Cutaneous 18Lymphoma, Large-Cell, Anaplastic 18Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 17

Interventions

Epoetin Alfa 7Darbepoetin alfa 6epoetin beta 4Lenalidomide 4Cyclophosphamide 4ACE-011 4fludarabine 3Busulfan 3thymoglobulin 2telapristone acetate 2luspatercept 2fludarabine phosphate 2Cyclosporine 2Antilymphocyte Serum 2AP 1903 reagent 211-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2vactosertib 1ruxolitinib 1roxadustat 1obinutuzumab 1ibrutinib 1fosphenytoin 1ferrous sulfate 1ferric gluconate 1ferric carboxymaltose 1eltrombopag 1angiotensin I (1-7) 1Whole-Body Irradiation 1Thiotepa 1Therapeutics 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Anemia × Whole-Body Irradiation × Clear all
NCT00801931 2019-03-27

Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders

Columbia University

Phase 1/2 Terminated
1 enrolled 8 charts
CNSClassical hematologyLymphoidOther hematologic neoplasm

Anemia, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡